Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

Abstract Background Early prediction of treatment response is crucial for the optimal treatment of advanced breast cancer. We aimed to explore whether monitoring early changes in plasma human epidermal growth factor receptor 2 (HER2) levels using digital PCR (dPCR) could predict the treatment respon...

Full description

Bibliographic Details
Main Authors: Yi‐Kun Kang, Yi‐Ran Si, Jie Ju, Zhu‐Qing Jia, Nan‐Lin Hu, Hao Dong, Xue Wang, Jian Yue, Pei‐Di Jiang, Zhao‐Liang Li, Yun‐Yun Zhang, Yan Wang, Bing‐He Xu, Peng Yuan
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Cancer Medicine
Subjects:
breast cancer
digital PCR
plasma HER2
prediction threshold
therapy response
Online Access:https://doi.org/10.1002/cam4.5352

Internet

https://doi.org/10.1002/cam4.5352

Similar Items